piracetam has been researched along with Parkinson Disease, Secondary in 2 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sano, M | 1 |
| Stern, Y | 1 |
| Marder, K | 1 |
| Mayeux, R | 1 |
1 trial available for piracetam and Parkinson Disease, Secondary
| Article | Year |
|---|---|
A controlled trial of piracetam in intellectually impaired patients with Parkinson's disease.
Topics: Aged; Aged, 80 and over; Cognition Disorders; Double-Blind Method; Humans; Middle Aged; Parkinson Di | 1990 |
1 other study available for piracetam and Parkinson Disease, Secondary
| Article | Year |
|---|---|
[Piracetam in the modern pharmacotherapy of the Parkinson syndrome].
Topics: Female; Humans; Middle Aged; Parkinson Disease, Secondary; Piracetam; Pyrrolidinones; Tremor | 1978 |